Investigating stroma-mediated resistance to gemcitabine, using a novel fluroescence-based coculture model of pancreatic cancer

Investigating stroma-mediated resistance to gemcitabine, using a novel fluroescence-based coculture model of pancreatic cancer

Bibliographic Details
Main Author:	Xu, Ruiling
Published:	University of Cambridge 2015
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.709342

Similar Items

Phagocytosis by stroma confounds coculture studies
by: Sophie A. Herbst, et al.
Published: (2021-09-01)

Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer
by: Ashenafi Bulle, et al.
Published: (2020-03-01)

The role of osteopontin-mediated autophagy in gemcitabine resistance of pancreatic cancer
by: Yu-TingHuang, et al.
Published: (2017)

Mechanisms of gemcitabine resistance in pancreatic cancer
by: Melling, J.
Published: (2017)

Tumor-stroma interaction mediated by tissue transglutaminase in pancreatic cancer
by: Lee, Jiyoon
Published: (2015)

Molecular mechanisms of acquired gemcitabine resistance in pancreatic cancer
by: Qin, Li
Published: (2015)

Role of ABCC5 in Gemcitabine Resistance in Pancreatic Cancer
by: Bugde, Piyush
Published: (2019)

Gene Expression Analysis of In Vitro Cocultures to Study Interactions between Breast Epithelium and Stroma
by: Patricia Casbas-Hernandez, et al.
Published: (2011-01-01)

Pancreatic Cancer Chemoresistance to Gemcitabine
by: Manoj Amrutkar, et al.
Published: (2017-11-01)

Targeting the Stroma in the Management of Pancreatic Cancer
by: Penelope Edwards, et al.
Published: (2021-07-01)

Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors
by: Kentaro Minami, et al.
Published: (2015-03-01)

Cytosolic 5′-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolitesResearch in context
by: Melanie S. Patzak, et al.
Published: (2019-02-01)

Review of molecular mechanisms underlying gemcitabine resistance in pancreatic cancer
by: A. Rajabpour, et al.
Published: (2017-10-01)

Soluble stroma‐related biomarkers of pancreatic cancer
by: Andrea Resovi, et al.
Published: (2018-08-01)

Tumour–stroma interactions in an organotypic culture model of pancreatic cancer
by: Froeling, Fieke E. M.
Published: (2011)

Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway
by: Yunjiang Zhou, et al.
Published: (2019-04-01)

Predictive modeling of in vivo response to gemcitabine in pancreatic cancer.
by: James J Lee, et al.
Published: (2013-01-01)

Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance
by: Ji-Hyun Lee, et al.
Published: (2018-01-01)

Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
by: Ru Chen, et al.
Published: (2017-08-01)

Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells
by: Papa Anne-Laure, et al.
Published: (2012-09-01)

Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells
by: Papa, Anne-Laure, et al.
Published: (2013)

m6A Methyltransferase METTL14-Mediated Upregulation of Cytidine Deaminase Promoting Gemcitabine Resistance in Pancreatic Cancer
by: Congjun Zhang, et al.
Published: (2021-08-01)

Differential Contribution of Pancreatic Fibroblast Subsets to the Pancreatic Cancer StromaSummary
by: Paloma E. Garcia, et al.
Published: (2020-01-01)

The Role of the Stroma and CYR61 in Chemoresistance in Pancreatic Cancer
by: Hesler, Rachel Anne
Published: (2016)

Gemcitabine Combination Nano Therapies for Pancreatic Cancer
by: Kamalika Samanta, et al.
Published: (2019-11-01)

Tissue Transglutaminase Activates Cancer-Associated Fibroblasts and Contributes to Gemcitabine Resistance in Pancreatic Cancer
by: Jiyoon Lee, et al.
Published: (2016-11-01)

TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo.
by: Jia Cao, et al.
Published: (2015-01-01)

GATA1 Promotes Gemcitabine Resistance in Pancreatic Cancer through Antiapoptotic Pathway
by: Zhenyu Chang, et al.
Published: (2019-01-01)

Gemcitabine Resistance Elicits a Calcium Dependent Epigenetic Reprogramming in Pancreatic Cancer
by: Kutschat, Ana Patricia
Published: (2021)

Pharmacokinetic and Pharmacodynamic Analysis of Gemcitabine and Birinapant Combinations in Pancreatic Cancer
by: Zhu, Xu
Published: (2017)

Antitumor effect of gemcitabine-loaded albumin nanoparticle on gemcitabine-resistant pancreatic cancer induced by low hENT1 expression
by: Guo ZY, et al.
Published: (2018-08-01)

Dynamic Stromal Alterations Influence Tumor-Stroma Crosstalk to Promote Pancreatic Cancer and Treatment Resistance
by: Kendelle J. Murphy, et al.
Published: (2021-07-01)

Role of Tumor and Stroma-Derived IGF/IGFBPs in Pancreatic Cancer
by: Divya Thomas, et al.
Published: (2020-05-01)

Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma
by: Neesse A, et al.
Published: (2013-12-01)

Mechanisms of gemcitabine resistance in a pancreatic adenocarcinoma cell line
by: Levett, Alan James
Published: (2017)

Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer Cells
by: Xu Zhu, et al.
Published: (2018-02-01)

Ursolic acid increases drug sensitivity of gemcitabine-resistant human pancreatic cancer cell
by: Zih-Ying Li, et al.
Published: (2019)

Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells
by: Dandan Li, et al.
Published: (2018-07-01)

Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer
by: Amber Blaauboer, et al.
Published: (2020-09-01)

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer
by: Habermehl Daniel, et al.
Published: (2012-03-01)

Cannot write session to /tmp/vufind_sessions/sess_rpj2gnga4uor1dl84m40nfe2tr